ArticleCanadian oncology nursing journal = Revue canadienne de nursing oncologique2025
Do not disturb: Use of wearable biosensor technology to minimize sleep disruptions in patients with hematological malignancies.
Article in Canadian oncology nursing journal = Revue canadienne de nursing oncologique, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with hematological malignancies frequently suffer from sleep disruptions during hospitalization, primarily due to frequent night-time interventions such as vital signs monitoring, which occurs at least three times during the night shift. Consequently, the sleep of these patients is interrupted each time a nurse checks their vitals. Minimizing disturbances to sleep in cancer patients is essential, as poor sleep quality has been associated with poorer responses to treatment and reduced overall survival (Strøm et al., 2022). This paper proposes the use of wearable biosensor technology over night in the inpatient setting to monitor patients' vital signs remotely and, thus, minimize disruptions to their sleep. The importance of improving sleep in this patient population and the potential for use of this technology necessitates further research on the analytical and clinical validity of wearable biosensors for use with hospitalized malignant hematology patients. The paper concludes with future recommendations and implications of this technology for the nursing profession.
Identifiers
40874106PMC12379872What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.